Clinical trials: Alopecia, Androgenetic
Alopecia
Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia
The aim of the study is to evaluate the therapeutic efficiency of minoxidil solution iontophoresis on Androgenic Alopecia.
- Trial name
- NCT07056933
- Testing
- Minoxidil solution iontophoresis, saline solution iontophoresis
- Where
- Egypt
- Volunteers
- 25 people
- Sponsor
- Cairo University
Alopecia
A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia
The aim of this Phase III study is to compare the efficacy, safety and tolerability of dutasteride (0.5mg) with placebo for 6 months, in Korean male subjects with androgenetic alopecia in the vertex region, types IIIv, IV and V…
- Trial name
- NCT00441116
- Testing
- Dutasteride 0.5mg oral tablets
- Volunteers
- 153 people
- Sponsor
- GlaxoSmithKline
Female Pattern Hair Loss
Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss
The study will be included 60 women with FPHL. The diagnosis of FPHL will be established by clinical (Ludwig classification) and trichoscopic evaluation of frontal and occipital regions of the scalp.
- Trial name
- FPHL (NCT04090801)
- Testing
- Topical minoxidil 5% in 90% ethanol and 5% propylene glycol, Topical minoxidil 5% in pure ethanol alone
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Sohag University
Androgenetic Alopecia
Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia
The investigators plan to conduct a clinical trial to assess the effects and safety of platelet rich plasma on androgenetic alopecia.
- Trial name
- NCT02074943
- Testing
- PRP
- Where
- Canada
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Vancouver General Hospital
Androgenetic Alopecia, Androgenic Alopecia
JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil
Androgenetic alopecia is a common form of progressive hair loss. This prospective single-arm pre-post interventional study aims to assess tissue Janus Kinase 2 (JAK2) expression in patients with androgenetic alopecia by comparing…
- Trial name
- NCT07563036
- Testing
- Topical Minoxidil 5% Solution, Scalp Punch Biopsy, Tissue JAK2 Protein Measurement by ELISA
- Where
- Egypt
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- Kasr El Aini Hospital
Androgenic Alopecia
Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
An Open-label, Randomized, Multiple-dose, Crossover Study to Evaluate the Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects with Androgenic Alopecia.
- Trial name
- NCT02824380
- Testing
- DA-4001 H, DA-4001 L
- Where
- South Korea
- Volunteers
- 14 people
- Sponsor
- Dong-A ST Co., Ltd.
Androgenetic Alopecia, AGA
Efficacy and Safety of VDPHL01 in Males With AGA
This study will evaluate the safety and efficacy of VDPHL01 in male subjects with Androgenetic Alopecia (AGA). AGA (or male pattern baldness) is a genetic disorder caused by an excessive (too much) hair follicle response to…
- Conditions
- Androgenetic Alopecia, AGA, Male Pattern Baldness
- Trial name
- NCT06724614
- Testing
- VDPHL01
- Where
- 44 sites in United States
- Volunteers
- 480 people
- Sponsor
- Veradermics, Inc.
Androgenetic Alopecia
Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia
This study evaluated the efficacy and safety of two concentrations of CosmeRNA-ARI Anti Hair Loss Tonic in adults with androgenetic alopecia.
- Trial name
- NCT07898566
- Testing
- Low-Concentration CosmeRNA-ARI Anti Hair Loss Tonic, High-Concentration CosmeRNA-ARI Anti Hair Loss Tonic, Vehicle Control Tonic Without CosmeRNA-AR
- Where
- South Korea
- Volunteers
- 90 people
- Sponsor
- BIONEER Corporation
Alopecia, Androgenetic
Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
The purpose of this study is to confirm the clinical efficacy and the safety of P-3074 in participants with androgenetic alopecia.
- Trial name
- NCT03004469
- Testing
- P-3074, Finasteride, P-3074 Vehicle
- Where
- 46 sites in Belgium, Germany and 3 more
- Volunteers
- 458 people
- Sponsor
- Polichem S.A.
Androgenetic Alopecia, Male Pattern Baldness
The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss
Beta-catenin, the transducer of Wnt signaling, is critical in development, growth, and regeneration of hair. In the absence of Wnt signals, cytoplasmic β-catenin is maintained at low level through regulation by GSK-3…
- Trial name
- NCT01548066
- Testing
- Valproic Acid
- Where
- South Korea
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Seoul National University Hospital
Androgenetic Alopecia
Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia
The current study aims to show efficacy of twice daily application of 5% Minoxidil Topical Foam (MTF) formulation compared to placebo in the temple region of male patients with androgenetic alopecia after 24 weeks as well as to…
- Trial name
- NCT01319370
- Testing
- Minoxidil, vehicle of 5% Minoxidil topical foam
- Where
- Germany
- Volunteers
- 70 people
- Sponsor
- Natalie GARCIA BARTELS
Androgenetic Alopecia, Pattern Baldness
Evaluation of the Niostem Headset for Hair Growth and Hair Quality
This double-blind, randomized, placebo-controlled clinical trial evaluates the Niostem headset, an electronic device designed to support hair growth, reduce hair loss, and improve hair quality.
- Trial name
- NCT06994819
- Testing
- niostem headset (Active)
- Where
- Germany
- Volunteers
- 101 people, healthy volunteers welcome
- Sponsor
- Mane Biotech GmbH
Dermatology, Female Pattern Baldness
Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss
The trial aims to study efficay of topical vitamin D analogue in treatment of female pattern hair loss cases
- Trial name
- NCT06333600
- Testing
- Topical minoxidil, Topical Vitamin D, Saline spray
- Where
- Egypt
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Sohag University
Alopecia, Androgenetic
A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)
Multi-center, fixed volume, randomized, double-blind, vehicle-controlled, parallel group, dose escalation comparison study of TDM-105795 in male subjects, 18 to 55 years old, with Androgenetic Alopecia (AGA).
- Trial name
- AGA (NCT04913519)
- Testing
- TDM-105795
- Where
- 2 sites in United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Technoderma Medicines Inc.
Female Pattern Baldness
Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
The goal of this clinical trial is to evaluate the efficacy and safety of OMA102 1 mg and OMA102 2 mg versus placebo in the treatment of female pattern hair loss.
- Trial name
- GENERA (NCT05824065)
- Testing
- OMA102
- Where
- Brazil
- Volunteers
- 504 people
- Sponsor
- EMS
Androgenetic Alopecia, Female Pattern Hair Loss
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
The purpose of this study is to determine in women the risk/benefit profile and non-inferiority of a topical 5% Minoxidil foam formulation applied once daily for the treatment of androgenetic alopecia in comparison to 2% MTS used…
- Trial name
- NCT00958750
- Testing
- minoxidil
- Where
- Germany
- Volunteers
- 113 people
- Sponsor
- Charite University, Berlin, Germany
Androgenetic Alopecia (AGA)
Low Dose Oral Minoxdil in Androgenic Alopecia
In order to successfully treat androgenetic alopecia (AGA), this study compares the efficacy of low-dose oral minoxidil dosages of 0.25 mg and 1 mg.
- Trial name
- NCT07018349
- Testing
- 2.5% Oral minoxidil, 1% Oral Minoxidil
- Where
- Pakistan
- Volunteers
- 76 people
- Sponsor
- Jinnah Postgraduate Medical Centre
Alopecia
Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women
The primary objective of this proposal is to conduct a study that assesses the safety, feasibility and efficacy of using PRP to treat this type of hair loss.
- Trial name
- NCT03488108
- Testing
- Platelet Rich Plasma, Minoxidil Foam
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Mayo Clinic
Androgenic Alopecia
Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation
To compare the efficacy of platlet rich plasma and Nanofat injection as adjuvant therapies with FUE hair transplantation in improving graft survival rate, To measure hair density and thickness postoperatively using dermoscopy or…
- Trial name
- NCT07287579
- Testing
- hair transplantation
- Volunteers
- 30 people
- Sponsor
- Sohag University
Male Pattern Hair Loss, Androgenetic Alopecia
Topical Bimatoprost Effect on Androgen Dependent Hair Follicles
The purpose of this study is to determine the effect of bimatoprost solution on scalp hair growth. Bimatoprost 0.03% ophthalmic solution is currently approved by the FDA for treatment of glaucoma (Lumigan™) and for thickening of…
- Trial name
- NCT02170662
- Testing
- Bimatoprost
- Volunteers
- 33 people
- Sponsor
- Duke University